Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CIGNA CORPORATION

(CI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cigna : Neither Cigna nor Anthem Win Damages After Failed Deal

09/01/2020 | 02:48am EDT

By Anna Wilde Mathews and Peg Brickley

Cigna Corp. and Anthem Inc. won't have to pay damages to one another over their failed $48 billion merger deal, a Delaware judge decided Monday, potentially resolving a bitter, yearslong legal battle that had the two insurance giants trading accusations of skulduggery.

In dueling lawsuits, each of the health-insurance giants sought billions of dollars in damages from the other. Both companies argued that its erstwhile partner had sabotaged their proposed combination, which foundered in 2017 after court rulings against the merger on antitrust grounds. Cigna wanted damages of $14.7 billion, along with a breakup fee of about $1.8 billion, from Anthem. Anthem sought damages of $21.1 billion from Cigna.

Vice Chancellor J. Travis Laster, of the Delaware Chancery Court, wrote that Anthem had sought to complete the merger and "chose a sound strategy and took all of the actions necessary and appropriate to pursue it." Cigna, he said, had breached its obligation to try to consummate the deal: "Rather than seeking to complete the Merger, Cigna sought to derail it," he wrote.

Calling the drama a "corporate soap opera," Judge Laster attached blame to both sides. Cigna proved that it was likely that the deal would have been blocked regardless of its actions, he wrote. In the end, "each party must bear the losses it suffered as a result of their star-crossed venture."

Shares in Cigna fell 2.1% on the New York Stock Exchange, while shares in Anthem rose 1.5%.

Investors had largely discounted the likelihood of sizable damage awards in the litigation, but some believed Cigna might still get the breakup fee, which the judge didn't uphold, said Matthew Borsch, an analyst with BMO Capital Markets. "That was a little bit of a positive surprise for Anthem investors, and a little bit of a negative surprise for Cigna investors," he said.

In a written statement, a spokeswoman for Cigna said the company is "pleased that the Court agreed with us that Cigna did not cause the merger to fail." The company still believes in its case and is "evaluating our options with respect to appeal," she said.

A spokeswoman for Anthem said the insurer is "satisfied with the decision determining that Cigna breached its obligation to use best efforts to obtain regulatory approval for the merger," and forfeited the breakup fee.

Anthem said in July 2015 that it would acquire Cigna, in a combination the two insurers initially pitched as bringing together complementary assets. In 2016, the Justice Department filed an antitrust suit to block the deal and courts sided with the antitrust enforcers, ruling against the merger in February 2017 and again later that year on appeal.

Behind the scenes, conflict between the two companies festered even as they pursued the deal. Each filed suit against the other after the antitrust rulings. During the litigation, they traded accusations of deception. Anthem claimed that Cigna and its chief executive, David Cordani, tried to sabotage the deal partly over concern about Mr. Cordani's future role in the combined company.

In his decision, Judge Laster wrote that by the spring of 2016, the Cigna leadership team "wanted the transaction to fail so they could continue managing Cigna as an independent company," and the company orchestrated a campaign to undermine the deal. For its part, Anthem misleadingly tried to portray its relationship with Cigna as solid while trying to hold the deal together, among other questionable actions, Judge Laster wrote.

Write to Anna Wilde Mathews at anna.mathews@wsj.com and Peg Brickley at peg.brickley@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
ANTHEM, INC. 0.39% 436.24 Delayed Quote.34.96%
CIGNA CORPORATION 0.02% 215.67 Delayed Quote.3.95%
All news about CIGNA CORPORATION
10/20Cigna Corporation Adds Iora Primary Care to Medicare Advantage Network in Phoenix Area
CI
10/19Cigna Expands its Medicare Business to Portland, Offering Medicare Advantage Plans in S..
CI
10/19Cigna Appoints Lindy Hinman to Lead its Medicare Advantage Plans in Oregon and Washingt..
CI
10/12WALL STREET STOCK EXCHANGE : It's just a period of market normalization
10/12ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex...
10/11AM BEST : Places Credit Ratings of Cigna Life Insurance New Zealand Limited Under Review W..
BU
10/11AM BEST : Comments on Credit Ratings of Cigna Corporation Following Asia-Pacific Business ..
BU
10/11CIGNA : UBS Adjusts Price Target on Cigna to $244 From $285, Maintains Buy Rating
MT
10/11CIGNA : AM Best Comments on Credit Ratings of Chubb Ltd and Subsidiaries Following Announc..
AQ
10/08Financial Stocks Slip Premarket Friday
MT
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Financials (USD)
Sales 2021 171 B - -
Net income 2021 5 356 M - -
Net Debt 2021 27 016 M - -
P/E ratio 2021 13,8x
Yield 2021 1,86%
Capitalization 73 334 M 73 334 M -
EV / Sales 2021 0,59x
EV / Sales 2022 0,54x
Nbr of Employees 72 963
Free-Float 85,4%
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 215,62 $
Average target price 260,50 $
Spread / Average Target 20,8%
EPS Revisions
Managers and Directors
David Michael Cordani President, Chief Executive Officer & Director
Brian C. Evanko Chief Financial Officer & Executive Vice President
Isaiah Harris Independent Chairman
Steven B. Miller Chief Clinical Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
CIGNA CORPORATION3.95%73 334
UNITEDHEALTH GROUP28.08%423 832
ANTHEM, INC.34.96%105 474
HUMANA INC.12.57%59 552
CENTENE CORPORATION13.23%39 629
MOLINA HEALTHCARE, INC.39.93%17 380